Statin-induced Kruppel-like factor 2 expression in human and mouse T cells reduces inflammatory and pathogenic responses

Journal of Clinical Investigation

Volumn 120, Issue 6, 2010, Pages 1961-1970

  Bu, De Xiu ^a   Tarrio, Margarite ^a   Grabie, Nir ^a   Zhang, Yuzhi ^a   Yamazaki, Hiroyuki ^a   Stavrakis, George ^a   Maganto Garcia, Elena ^a   Pepper Cunningham, Zachary ^a   Jarolim, Petr ^a   Aikawa, Masanori ^a   García Cardeña, Guillermo ^a   Lichtman, Andrew H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; FLUINDOSTATIN; GAMMA INTERFERON; ISOPRENOID; KRUPPEL LIKE FACTOR 2; MEVALONIC ACID; MEVINOLIN; PITAVASTATIN; RETROVIRUS VECTOR; SHORT HAIRPIN RNA; SIMVASTATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOPATHOGENESIS; LYMPHOCYTE PROLIFERATION; MOUSE; MYOCARDITIS; NONHUMAN; PATHOGENICITY; PRENYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR GENE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ACYL COENZYME A; ANIMALS; ENDOTHELIAL CELLS; GENE EXPRESSION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLAMMATION; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PRENYLATION; T-LYMPHOCYTES; TRANSCRIPTION FACTORS;

EID: 77953185420     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI41384     Document Type: Article

References (39)

1. Kuo CT, Veselits ML, Barton KP, Lu MM, Clendenin C, Leiden JM. The LKLF transcription factor is required for normal tunica media formation and blood vessel stabilization during murine embryo-genesis. Genes Dev. 1997;11(22):2996-3006.
2. Buckley AF, Kuo CT, Leiden JM. Transcription factor LKLF is sufficient to program T cell quiescence via a c-Myc-dependent pathway. Nat Immunol. 2001;2(8):698-704.
3. Wu J, Lingrel JB. KLF2 inhibits Jurkat T leukemia cell growth via upregulation of cyclin-dependent kinase inhibitor p21WAF1/CIP1. Oncogene. 2004;23(49):8088-8096. (Pubitemid 39531849)
4. Schober SL, Kuo CT, Schluns KS, Lefrancois L, Leiden JM, Jameson SC. Expression of the transcription factor lung Kruppel-like factor is regulated by cytokines and correlates with survival of memory T cells in vitro and in vivo. J Immunol. 1999;163(7):3662-3667. (Pubitemid 29450887)
5. Grayson JM, Murali-Krishna K, Altman JD, Ahmed R. Gene expression in antigen-specific CD8+ T cells during viral infection. J Immunol. 2001;166(2):795-799. (Pubitemid 32060230)
6. Wu J, Lingrel JB. Kruppel-like factor 2, a novel immediate-early transcriptional factor, regulates IL-2 expression in T lymphocyte activation. J Immunol. 2005;175(5):3060-3066. (Pubitemid 41170525)
7. Carlson CM, et al. Kruppel-like factor 2 regulates thymocyte and T-cell migration. Nature. 2006;442(7100):299-302.
8. Kuo CT, Veselits ML, Leiden JM. LKLF: A transcriptional regulator of single-positive T cell quiescence and survival. Science. 1997;277(5334):1986- 1990.
9. Sebzda E, Zou Z, Lee JS, Wang T, Kahn ML. Transcription factor KLF2 regulates the migration of naive T cells by restricting chemokine receptor expression patterns. Nat Immunol. 2008;9(3):292-300. (Pubitemid 351267326)
10. Weinreich MA, Takada K, Skon C, Reiner SL, Jameson SC, Hogquist KA. KLF2 transcription-factor deficiency in T cells results in unrestrained cytokine production and upregulation of bystander chemokine receptors. Immunity. 2009;31(1):122-130.
11. Youssef S, et al. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature. 2002;420(6911):78-84. (Pubitemid 35291443)
12. Kwak B, Mulhaupt F, Myit S, Mach F. Statins as a newly recognized type of immunomodulator. Nat Med. 2000;6(12):1399-1402. (Pubitemid 32001026)
13. Arnaud C, Braunersreuther V, Mach F. Toward immunomodulatory and anti-inf lammatory properties of statins. Trends Cardiovasc Med. 2005;15(6):202-206. (Pubitemid 41338006)
14. Hakamada-Taguchi R, et al. Inhibition of hydroxy-methylglutaryl-coenzyme a reductase reduces Th1 development and promotes Th2 development. Circ Res. 2003;93(10):948-956. (Pubitemid 37441285)
15. Mausner-Fainberg K, et al. The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells. Atherosclerosis. 2008;197(2):829-839. (Pubitemid 351417882)
16. Frenette PS. Locking a leukocyte integrin with statins. N Engl J Med. 2001;345(19):1419-1421.
17. Blank N, et al. Atorvastatin inhibits T cell activation through 3-hydroxy-3-methylglutaryl coenzyme A reductase without decreasing cholesterol synthesis. J Immunol. 2007;179(6):3613-3621.
18. Ghittoni R, et al. Simvastatin inhibits T-cell activation by selectively impairing the function of Ras superfamily GTPases. FASEB J. 2005;19(6):605-607. (Pubitemid 40471259)
19. Goldman F, Hohl R, Crabtree J, Lewis-Tibesar K, Koretzky G. Lovastatin inhibits T-cell antigen receptor signaling independent of its effects on ras. Blood. 1996;88(12):4611-4619. (Pubitemid 26419144)
20. Dykstra M, Cherukuri A, Sohn HW, Tzeng S-J, Pierce SK. Location is everything: lipid rafts and immune cell signaling. Annu Rev Immunol. 2003;21:457-481. (Pubitemid 37174538)
21. Parmar KM, Nambudiri V, Dai G, Larman HB, Gimbrone MA Jr, Garcia-Cardena G. Statins exert endothelial atheroprotective effects via the KLF2 transcription factor. J Biol Chem. 2005;280(29):26714-26719. (Pubitemid 41040703)
22. Sen-Banerjee S, et al. Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells. Circulation. 2005;112(5):720-726. (Pubitemid 41099052)
23. Atkins GB, Jain MK. Role of Kruppel-like transcription factors in endothelial biology. Circ Res. 2007;100(12):1686-1695. (Pubitemid 46987860)
24. Garcia-Cardena G, Gimbrone MA Jr. Biomechanical modulation of endothelial phenotype: implications for health and disease. Handb Exp Pharmacol. 2006;(176 pt 2):79-95.
25. van Thienen JV, et al. Shear stress sustains atheroprotective endothelial KLF2 expression more potently than statins through mRNA stabilization. Cardiovasc Res. 2006;72(2):231-240.
26. Tuomisto TT, et al. Simvastatin has an anti-inflammatory effect on macrophages via upregulation of an atheroprotective transcription factor, Kruppel-like factor 2. Cardiovasc Res. 2008;78(1):175-184.
27. Dunn SE, et al. Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin. J Exp Med. 2006;203(2):401-412.
28. Kinderlerer AR, et al. KLF2-dependent, shear stress-induced expression of CD59: a novel cytoprotective mechanism against complement-mediated injury in the vasculature. J Biol Chem. 2008;283(21):14636-14644.
29. Yamada T, Park CS, Mamonkin M, Lacorazza HD. Transcription factor ELF4 controls the proliferation and homing of CD8+ T cells via the Kruppel-like factors KLF4 and KLF2. Nat Immunol. 2009;10(6):618-626.
30. Grabie N, et al. IL-12 is required for differentiation of pathogenic CD8+ T cell effectors that cause myocarditis. J Clin Invest. 2003;111(5):671-680. (Pubitemid 36278585)
31. Taqueti VR, et al. T-bet controls pathogenicity of CTLs in the heart by separable effects on migration and effector activity. J Immunol. 2006;177(9):5890-5901.
32. Greenwood J, Steinman L, Zamvil SS. Statin therapy and autoimmune disease: from protein prenylation to immunomodulation. Nat Rev Immunol. 2006;6(5):358-370.
33. Ghittoni R, Lazzerini PE, Pasini FL, Baldari CT. T lymphocytes as targets of statins: molecular mechanisms and therapeutic perspectives. Inflamm Allergy Drug Targets. 2007;6(1):3-16. (Pubitemid 46488294)
34. Bai A, Hu H, Yeung M, Chen J. Kruppel-like factor 2 controls T cell trafficking by activating L-selectin (CD62L) and sphingosine-1-phosphate receptor 1 transcription. J Immunol. 2007;178(12):7632-7639. (Pubitemid 46898033)
35. Grabie N, et al. Endothelial programmed death-1 ligand 1 (PD-L1) regulates CD8+ T-cell mediated injury in the heart. Circulation. 2007;116(18):2062-2071. (Pubitemid 350023752)
36. Stein JV. How to be naive. Immunity. 2009;31(1):9-11.
37. Yi T, et al. Amelioration of human allograft arterial injury by atorvastatin or simvastatin correlates with reduction of interferon-gamma production by infiltrating T cells. Transplantation. 2008;86(5):719-727.
38. Grabie N, et al. Neutrophils sustain pathogenic CD8+ T cell responses in the heart. Am J Pathol. 2003;163(6):2413-2420. (Pubitemid 37466482)
39. Young A, et al. Flow activation of AMP-activated protein kinase in vascular endothelium leads to Kruppel-like factor 2 expression. Arterioscler Thromb Vasc Biol. 2009;29(11):1902-1908.